Pulmatrix Enters Cross License Agreement With MannKind To Use Cricket Inhalation Device For Delivery Of PUR3100 And Other Dry Powder Formulations For Neurological Diseases
Pulmatrix Enters Cross License Agreement With MannKind To Use Cricket Inhalation Device For Delivery Of PUR3100 And Other Dry Powder Formulations For Neurological Diseases
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.